Molecular Characterization of ADP-ribosyl Cyclase Coupled with Receptors
与受体偶联的 ADP-核糖基环化酶的分子表征
基本信息
- 批准号:12480228
- 负责人:
- 金额:$ 8.45万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We previously reported that stimulation of β-adrenergic and angiotensin II receptors modulates activity of ADP-ribosyl cyclase, a synthetic enzyme of cADP-ribose, and showed that cADP-ribose is a critical molecule in sympathetic potentiation of heart contraction, post-natal heart growth, and neuron-glia interaction. In the present study, we used the same strategy to explore the idea mat cADP-ribose is a second messenger downstream of the mGluRs. We first measured ADP-ribosyl cyclase activity in crude membranes from various rat and mouse nervous tissues in the presence or absence of glutamate and/or GTP. Second, the coupling preference of mGluRs to ADP-ribosyl cyclase was examined in NG108-15 neuroblastoma x glioma hybrid cells over-expressing each subtype.Glutamate stimulates ADP-ribosyl cyclase activity in rat or mouse crude membranes of retina via group III mGIuRs or in superior cervical ganglion via group I mGluRs. The retina of mGluR6 deficient mice showed no increase in the ADP-ribosyl cyclase level in response to glutamate. GTP enhanced the initial rate of basal and glutamate-stimutated cyclase activity. GTP-γ-S also stimulated basal activity. To determine whether the coupling mode of mGluRs to ADP-ribosyl cyciase is a feature common to individual cloned mGIuRs, we expressed each mGluR subtype in NG108-15 neuroblastoma x glioma hybrid cells. The glutamate-induced stimulation of the cyclase occurs preferentially in NG108-15 cells over-expressing mGluRs1, 3, 5, and 6. Cells expressing mGluR2 or mGluRs4 and 7 exhibit inhibition or no coupling, respectively. Glutamate-induced activation or inhibition of the cyclase activity was eliminated after pretreatment with cholera or pertussis toxin, respectively. Thus, the subtype-specific coupling of mGIuRs to ADP-ribosyl cyclase via G proteins suggests that some glutamate-evoked neuronal function is mediated by cADP-ribose.
我们之前报道过,刺激 β-肾上腺素能和血管紧张素 II 受体可调节 ADP-核糖基环化酶(cADP-核糖的合成酶)的活性,并表明 cADP-核糖是心脏收缩、产后心脏交感神经增强的关键分子。在本研究中,我们使用相同的策略来探索 cADP-核糖是神经元下游的第二信使的想法。我们首先测量了在存在或不存在谷氨酸和/或 GTP 的情况下来自各种大鼠和小鼠神经组织的粗膜中的 ADP-核糖基环化酶活性,其次,在 NG108-15 中检查了 mGluRs 与 ADP-核糖基环化酶的偶联偏好。神经母细胞瘤 x 神经胶质瘤杂交细胞过度表达每种亚型。谷氨酸刺激 ADP-核糖基环化酶活性在大鼠或小鼠的视网膜粗膜中,通过第 III 组 mGluR 或在上颈神经节中,通过第 I 组 mGluR。 mGluR6 缺陷小鼠的视网膜显示,谷氨酸对基础 GTP 的反应没有增加。和谷氨酸刺激的环化酶活性也刺激了mGluRs的基础活性。 ADP-核糖基环化酶是单个克隆 mGluR 的共同特征,我们在 NG108-15 神经母细胞瘤 x 神经胶质瘤杂交细胞中表达每种 mGluR 亚型,谷氨酸诱导的环化酶刺激优先发生在过表达 mGluRs1 的 NG108-15 细胞中,3。 、5和6.表达mGluR2或的细胞mGluRs4和7分别表现出抑制或无偶联,谷氨酸诱导的环化酶活性的激活或抑制分别在用霍乱或百日咳毒素预处理后被消除,因此,mGluRs通过G蛋白与ADP-核糖基环化酶的亚型特异性偶联。表明一些谷氨酸诱发的神经元功能是由 cADP-核糖介导的。
项目成果
期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Higashida, H., Hashii, M., Yokoyama, S., Hoshi, N., et al.: "Cyclic ADP-ribose as a second messenger revisited from a new aspect of signal transduction from receptors to ADP-ribosyl cyclase"Pharmacol.Ther.. 90(2-3). 283-296 (2001)
Higashida, H.、Hashii, M.、Yokoyama, S.、Hoshi, N.等人:“从受体到 ADP-核糖基环化酶信号转导的新方面重新审视环 ADP-核糖作为第二信使”Pharmacol
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Higashida, H. et al.: "Angiotensin II stimulates cyclic ADP-ribose formation in neneonatal rat cardiac myosytes"Biochem. J.. 352(1). 197-202 (2000)
Higashida, H. 等人:“血管紧张素 II 刺激新生大鼠心肌细胞中环状 ADP-核糖的形成”Biochem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Higashida,H.,Yokoyama,S.,Hashii,M. et al.: "Signal transduction from bradykinin, angiotensin, adrenergic and muscarinic receptors to effector enzymes, including ADP-ribosyl cyclase."Biological Chem.. 382. (2001)
东田,H.,横山,S.,桥井,M.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Higashida, H. et al.: "Cyclic ADP-ribose as a potential second messenger for neuronal Ca2+signaling"J Neurochem.. 76(2). 321-331 (2001)
Higashida, H. 等人:“环状 ADP-核糖作为神经元 Ca2 信号传导的潜在第二信使”J Neurochem.. 76(2)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Noda, M., Yasuda, S., Okada, M., Higashida, H., et al.: "Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways"J.Neurochem.. 84. 222-232 (2003)
Noda, M.、Yasuda, S.、Okada, M.、Higashida, H.等人:“在 C6 神经胶质瘤细胞中稳定表达的重组人血清素 5A 受体与多种信号转导途径偶联”J.Neurochem.. 84。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIGASHIDA Haruhiro其他文献
HIGASHIDA Haruhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIGASHIDA Haruhiro', 18)}}的其他基金
Neurochemical studies on molecules involved in social recognition and research on genes and therapy in autism.
涉及社会识别的分子的神经化学研究以及自闭症基因和治疗的研究。
- 批准号:
19200030 - 财政年份:2007
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
ADP-ribosyl cyclase coupled with dopamine receptors : Application to Parkinson's disease
ADP-核糖基环化酶与多巴胺受体偶联:在帕金森病中的应用
- 批准号:
15300124 - 财政年份:2003
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Purification and cloning of brain isoform of ADP-ribosyl cyclase
ADP-核糖基环化酶脑亚型的纯化和克隆
- 批准号:
09480221 - 财政年份:1997
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Delineating how nucleic acid sensing in tumor cells regulate anti-tumor immune responses
描述肿瘤细胞中的核酸传感如何调节抗肿瘤免疫反应
- 批准号:
10626284 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别:
Role of astrocytes and astrocytic CD38 in spinal opioid signaling
星形胶质细胞和星形胶质细胞 CD38 在脊髓阿片信号传导中的作用
- 批准号:
10452235 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Development of a potent and selective oral ENPP1 inhibitor for oncology
开发用于肿瘤学的有效且选择性口服 ENPP1 抑制剂
- 批准号:
10705273 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别:
Functional roles of GOF TP53 mutations in metastasis and immunosuppression of head and neck cancers
GOF TP53突变在头颈癌转移和免疫抑制中的功能作用
- 批准号:
10617289 - 财政年份:2022
- 资助金额:
$ 8.45万 - 项目类别: